NEOVOLTA INC (NEOV)

US6406551068 - Common Stock

3.15  -0.05 (-1.56%)

After market: 3.2396 +0.09 (+2.84%)

Fundamental Rating

4

Overall NEOV gets a fundamental rating of 4 out of 10. We evaluated NEOV against 91 industry peers in the Electrical Equipment industry. NEOV has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, NEOV is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year NEOV has reported negative net income.
In the past year NEOV has reported a negative cash flow from operations.
NEOV had negative earnings in each of the past 5 years.
In the past 5 years NEOV always reported negative operating cash flow.

1.2 Ratios

NEOV has a Return On Assets of -36.79%. This is in the lower half of the industry: NEOV underperforms 68.89% of its industry peers.
NEOV has a Return On Equity of -36.89%. This is comparable to the rest of the industry: NEOV outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -36.79%
ROE -36.89%
ROIC N/A
ROA(3y)-138.55%
ROA(5y)-95.72%
ROE(3y)-168.34%
ROE(5y)-113.81%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of NEOV (27.03%) is better than 63.33% of its industry peers.
NEOV's Gross Margin has improved in the last couple of years.
NEOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.65%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

The number of shares outstanding for NEOV has been increased compared to 1 year ago.
NEOV has more shares outstanding than it did 5 years ago.
NEOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 4169.40 indicates that NEOV is not in any danger for bankruptcy at the moment.
The Altman-Z score of NEOV (4169.40) is better than 100.00% of its industry peers.
NEOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4169.4
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

NEOV has a Current Ratio of 342.37. This indicates that NEOV is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NEOV (342.37) is better than 100.00% of its industry peers.
A Quick Ratio of 200.38 indicates that NEOV has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 200.38, NEOV belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 342.37
Quick Ratio 200.38

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.60% over the past year.
Looking at the last year, NEOV shows a very negative growth in Revenue. The Revenue has decreased by -23.79% in the last year.
The Revenue has been growing by 19.85% on average over the past years. This is quite good.
EPS 1Y (TTM)54.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.3%
Revenue 1Y (TTM)-23.79%
Revenue growth 3Y19.85%
Revenue growth 5YN/A
Sales Q2Q%-54.87%

3.2 Future

The Earnings Per Share is expected to grow by 27.72% on average over the next years. This is a very strong growth
Based on estimates for the next years, NEOV will show a very strong growth in Revenue. The Revenue will grow by 60.12% on average per year.
EPS Next Y41.67%
EPS Next 2Y25.83%
EPS Next 3Y27.72%
EPS Next 5YN/A
Revenue Next Year-26.32%
Revenue Next 2Y54.75%
Revenue Next 3Y60.12%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NEOV. In the last year negative earnings were reported.
Also next year NEOV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NEOV's earnings are expected to grow with 27.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.83%
EPS Next 3Y27.72%

0

5. Dividend

5.1 Amount

No dividends for NEOV!.
Industry RankSector Rank
Dividend Yield N/A

NEOVOLTA INC

NASDAQ:NEOV (9/18/2024, 8:18:08 PM)

After market: 3.2396 +0.09 (+2.84%)

3.15

-0.05 (-1.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap104.71M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.79%
ROE -36.89%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 27.03%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 342.37
Quick Ratio 200.38
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)54.6%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y41.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-23.79%
Revenue growth 3Y19.85%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y